# Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP

Study · id `cardio:ct-nct01486667` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01486667](<https://clinicaltrials.gov/study/NCT01486667>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01486667

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01486667. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01486667, source copy `cardio:ctgov-nct01486667-2011-12-08`, retrieved 2026-10-31)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01486667, source copy `cardio:ctgov-nct01486667-2011-12-08`, retrieved 2026-10-31)
- Primary completion: 2013-10 (anticipated) (ClinicalTrials.gov record NCT01486667, source copy `cardio:ctgov-nct01486667-2011-12-08`, retrieved 2026-10-31)
- Completion: Not reported
- Countries: Saudi Arabia (ClinicalTrials.gov record NCT01486667, source copy `cardio:ctgov-nct01486667-2011-12-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01486667-2011-12-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
- Condition: Dyslipidemia
- Intervention (Drug): levothyroxine
- Intervention (Drug): sugar pill
- Lead sponsor: King Saud University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: King Saud University (`cardio:org-king-saud-university`)

## Provenance

Content hash: 5edb3eee961837b9b56e6d7a2a19cfc2ddbf0399f9a7749a9e514a725cb41736
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
